Unknown

Dataset Information

Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis.


ABSTRACT: Objectives: Pneumocystis jirovecii pneumonia (PCP) is an AIDS-defining illness. In patients with HIV, the benefit of PCP prophylaxis is well-defined when the CD4 T-cell count decreases below 200 cells/μL. In other immunocompromised patients, the value of PCP prophylaxis is not always as well-established. This study aimed to describe the epidemiology of PCP in recent years and assess how many patients with PCP did or did not receive prophylaxis in the month preceding the infection. Material and Methods: A multicenter retrospective study was performed in 3 tertiary care hospital. A list of patients that underwent broncho-alveolar lavage sampling and Pneumocystis jirovecii (PJ) PCR testing was retrieved from the microbiology laboratories. An in-house PJ quantitativ

SUBMITTER: Dunbar A 

PROVIDER: S-EPMC7243458 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature